Institutions in New Jersey received $465.8M in NIH funding in fiscal year 2026 across 815 awards, #22 among states. Rutgers Biomedical and Health Sciences received the most, $222.8M, and the NIAID was the largest funding institute.
| Rank | Institution | Awards | NIH funding |
|---|---|---|---|
| 1 | Rutgers Biomedical and Health Sciences | 407 | $222.8M |
| 2 | Princeton University | 145 | $76.7M |
| 3 | Hackensack University Medical Center | 47 | $61.5M |
| 4 | Rutgers, the State University of N.j. | 98 | $43.3M |
| 5 | Rowan University | 21 | $8.6M |
| 6 | Rutgers the State University of Nj Newark | 15 | $7.4M |
| 7 | New Jersey Institute of Technology | 15 | $7.3M |
| 8 | Coriell Institute for Medical Research | 7 | $5.2M |
| 9 | Stevens Institute of Technology | 6 | $2.4M |
| 10 | Rutgers the State University of Nj Camden | 6 | $2.3M |
| 11 | Rowan University School/Osteopathic Medical | 5 | $2.3M |
| 12 | Taxis Pharmaceuticals, Inc. | 3 | $2.2M |
| 13 | Prokaryotics, Inc. | 3 | $1.9M |
| 14 | Analytical Diagnostic Solutions, Inc. | 3 | $1.7M |
| 15 | Kessler Foundation, Inc. | 4 | $1.6M |
| 16 | Nanonewron Llc | 1 | $1.5M |
| 17 | Plumeria Therapeutics, Inc. | 1 | $1.5M |
| 18 | Respirerx Pharmaceuticals Inc. | 1 | $1.5M |
| 19 | Psychogenics, Inc. | 2 | $1.3M |
| 20 | Montclair State University | 2 | $1.1M |
| 21 | Novopedics, Inc. | 1 | $1.0M |
| 22 | Linnaeus Therapeutics Inc | 1 | $1,000K |
| 23 | Kathera Bioscience Inc. | 1 | $995K |
| 24 | Lactiga Us Inc. | 1 | $969K |
| 25 | Fairleigh Dickinson University | 3 | $896K |
| Institute | Focus | Funding |
|---|---|---|
| NIAID | infectious disease, immunology and allergy | $108.7M |
| NIGMS | basic biomedical science and research training | $57.9M |
| NCI | cancer | $55.9M |
| NIMH | mental health | $40.2M |
| NINDS | neurology and stroke | $39.7M |
| NIA | aging and Alzheimer's disease | $25.5M |
| NICHD | child health, pregnancy and development | $23.3M |
| NIDA | addiction and substance use | $19.9M |
| NHLBI | heart, lung, blood and sleep | $19.9M |
| NIDDK | diabetes, digestive and kidney disease | $17.6M |
NIH awards to New Jersey institutions moved from $472.0M in fiscal year 2025 to $465.8M in 2026, a change of -1.3% against -0.3% nationally.
| Institution | FY2025 | FY2026 | Change |
|---|---|---|---|
| Coriell Institute for Medical Research | $17.5M | $5.2M | -70.3% |
| Rutgers Biomedical and Health Sciences | $231.9M | $222.8M | -3.9% |
| Rutgers the State University of Nj Newark | $11.3M | $7.4M | -35.2% |
| Rowan University School/Osteopathic Medical | $5.4M | $2.3M | -58.1% |
| Princeton University | $78.4M | $76.7M | -2.1% |
| Hackensack University Medical Center | $40.0M | $61.5M | +53.7% |
| Rowan University | $5.8M | $8.6M | +47.8% |
| New Jersey Institute of Technology | $5.3M | $7.3M | +37.9% |
| Stevens Institute of Technology | $1.7M | $2.4M | +43.2% |
| Nanonewron Llc | $980K | $1.5M | +55.2% |
Largest decreases first, then largest increases. Every state compared.
See New Jersey university research spending (all sources, NSF HERD) and every federal funder.
New Jersey is #22 on NIH funding by state.